ATE354584T1 - Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen - Google Patents
Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungenInfo
- Publication number
- ATE354584T1 ATE354584T1 AT04029270T AT04029270T ATE354584T1 AT E354584 T1 ATE354584 T1 AT E354584T1 AT 04029270 T AT04029270 T AT 04029270T AT 04029270 T AT04029270 T AT 04029270T AT E354584 T1 ATE354584 T1 AT E354584T1
- Authority
- AT
- Austria
- Prior art keywords
- solid phase
- unprotected
- aqueous solutions
- chemical ligation
- native chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
- C07K1/086—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4955397P | 1997-06-13 | 1997-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE354584T1 true ATE354584T1 (de) | 2007-03-15 |
Family
ID=21960431
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04029270T ATE354584T1 (de) | 1997-06-13 | 1998-06-12 | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen |
| AT98929035T ATE285415T1 (de) | 1997-06-13 | 1998-06-12 | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98929035T ATE285415T1 (de) | 1997-06-13 | 1998-06-12 | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US6326468B1 (de) |
| EP (1) | EP1001968B1 (de) |
| JP (1) | JP2002505672A (de) |
| AT (2) | ATE354584T1 (de) |
| AU (1) | AU745094B2 (de) |
| CA (1) | CA2292724A1 (de) |
| DE (2) | DE69837170T2 (de) |
| ES (2) | ES2235336T3 (de) |
| WO (1) | WO1998056807A1 (de) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184344B1 (en) * | 1995-05-04 | 2001-02-06 | The Scripps Research Institute | Synthesis of proteins by native chemical ligation |
| US6849428B1 (en) * | 1997-03-05 | 2005-02-01 | New England Biolabs, Inc. | Intein-mediated protein ligation of expressed proteins |
| DE69837170T2 (de) * | 1997-06-13 | 2007-11-22 | Amylin Pharmaceuticals, Inc., San Diego | Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen |
| US6844161B2 (en) | 1997-09-04 | 2005-01-18 | Gryphon Therapeutics, Inc. | Modular protein libraries and methods of preparation |
| AUPP589598A0 (en) | 1998-09-14 | 1998-10-08 | University Of Queensland, The | Novel peptides |
| US7001745B1 (en) * | 1998-09-30 | 2006-02-21 | New England Biolabs, Inc. | Intein mediated peptide ligation |
| EP1159289A1 (de) * | 1999-03-11 | 2001-12-05 | Gryphon Sciences | Chemische synthese und verwendung von löslichen membranproteinrezeptordomänen |
| SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| EP1307214A4 (de) * | 2000-08-11 | 2006-01-18 | Invitrogen Corp | Hochhomogene molekulare marker für ektrophorese |
| US20040014082A1 (en) * | 2000-08-11 | 2004-01-22 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
| US6977292B2 (en) * | 2000-09-01 | 2005-12-20 | Gryphon Therapeutics | Nucleophile-stable thioester generating compounds, methods of production and use |
| US7273923B2 (en) * | 2001-01-22 | 2007-09-25 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
| ATE346950T1 (de) * | 2001-03-09 | 2006-12-15 | Boston Probes Inc | Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen |
| GB0113657D0 (en) * | 2001-06-05 | 2001-07-25 | Geneprot Inc | Improved native chemical ligation with three or more components |
| EP2292273A3 (de) | 2001-10-10 | 2011-11-23 | BioGeneriX AG | Remodellierung und Glycokonjugation von Peptiden |
| WO2003106615A2 (en) * | 2002-06-10 | 2003-12-24 | Geneprot, Inc. | Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| ATE312605T1 (de) * | 2002-06-29 | 2005-12-15 | Aquanova Ger Solubilisate Tech | Isoflavonkonzentrate sowie verfahren zu ihrer herstellung |
| US7166574B2 (en) * | 2002-08-20 | 2007-01-23 | Biosurface Engineering Technologies, Inc. | Synthetic heparin-binding growth factor analogs |
| US7598224B2 (en) | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
| US8227411B2 (en) | 2002-08-20 | 2012-07-24 | BioSurface Engineering Technologies, Incle | FGF growth factor analogs |
| WO2004053460A2 (en) * | 2002-12-11 | 2004-06-24 | New England Biolabs, Inc. | Carrier-ligand fusions and uses thereof |
| US8034900B2 (en) * | 2002-12-30 | 2011-10-11 | Amylin Pharmaceuticals, Inc. | Water-soluble thioester and selenoester compounds and methods for making and using the same |
| CA2522345A1 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| SI1624891T2 (sl) * | 2003-05-06 | 2013-09-30 | Biogen Idec Hemophilia Inc. | Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije |
| WO2004105685A2 (en) * | 2003-05-22 | 2004-12-09 | Gryphon Therapeutics, Inc. | Displaceable linker solid phase chemical ligation |
| US7414028B1 (en) | 2004-02-04 | 2008-08-19 | Biosurface Engineering Technologies, Inc. | Growth factor analogs |
| US20080227696A1 (en) | 2005-02-22 | 2008-09-18 | Biosurface Engineering Technologies, Inc. | Single branch heparin-binding growth factor analogs |
| US20060024347A1 (en) * | 2004-02-10 | 2006-02-02 | Biosurface Engineering Technologies, Inc. | Bioactive peptide coatings |
| US7671012B2 (en) | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
| US7528105B1 (en) | 2004-02-10 | 2009-05-05 | Biosurface Engineering Technologies | Heterodimeric chain synthetic heparin-binding growth factor analogs |
| JP4895826B2 (ja) | 2004-02-20 | 2012-03-14 | バイオサーフェス エンジニアリング テクノロジーズ,インク. | 骨形成蛋白−2の正のモジュレーター |
| US7910593B2 (en) | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| EP1749022A2 (de) * | 2004-05-24 | 2007-02-07 | Rigel Pharmaceuticals, Inc. | Verfahren zur cyclisierung von synthetischen polymeren |
| KR20080003849A (ko) | 2005-03-31 | 2008-01-08 | 아밀린 파마슈티칼스, 인크. | 비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법 |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| US7674881B2 (en) * | 2005-10-07 | 2010-03-09 | The University Of Chicago | Convergent synthesis of proteins by kinetically controlled ligation |
| US20090118271A1 (en) * | 2005-10-19 | 2009-05-07 | Chugai Seiyaku Kabushiki Kaisha | Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug |
| US7820172B1 (en) | 2006-06-01 | 2010-10-26 | Biosurface Engineering Technologies, Inc. | Laminin-derived multi-domain peptides |
| CA2692240C (en) | 2006-06-22 | 2018-03-13 | Biosurface Engineering Technologies, Inc. | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis |
| EP2120985B1 (de) | 2007-02-05 | 2012-06-27 | Amylin Pharmaceuticals, Inc. | FN-38 Peptide zur Verwendung bei der Behandlung Psychotischer- und Angsterkrankungen |
| WO2009032133A2 (en) * | 2007-08-28 | 2009-03-12 | Ipsen Pharma S.A.S. | Methods and intermediates for chemical synthesis of polypeptides and proteins |
| EP2536287A4 (de) * | 2010-02-18 | 2015-10-07 | Advanced Proteome Therapeutics Inc | Ortsspezifische modifikation von proteinen durch chemische modifikation zur bildung von proteinkonjugaten, proteindimerbildung und stapelpeptide |
| MX349054B (es) | 2010-09-28 | 2017-07-07 | Aegerion Pharmaceuticals Inc | Leptinas altamente solubles. |
| BR112013007442A2 (pt) | 2010-09-28 | 2019-09-24 | Amylin Pharmaceuticals Llc | polipeptídeos construídos tendo duração de ação realçada |
| DK2729160T3 (da) | 2011-07-08 | 2019-07-01 | Aegerion Pharmaceuticals Inc | Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet |
| JP6006309B2 (ja) | 2011-07-08 | 2016-10-12 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
| FR2981352B1 (fr) * | 2011-10-17 | 2015-07-03 | Centre Nat Rech Scient | Procede de synthese de proteines |
| US9545449B2 (en) | 2012-05-11 | 2017-01-17 | Advanced Proteone Therapeutics Inc. | Site-specific labeling and targeted delivery of proteins for the treatment of cancer |
| WO2013177231A1 (en) | 2012-05-21 | 2013-11-28 | Massachusetts Institute Of Technology | Translocation of non-natural chemical entities through anthrax protective antigen pore |
| SG11201505926VA (en) | 2013-03-15 | 2015-09-29 | Biogen Ma Inc | Factor ix polypeptide formulations |
| US11273176B2 (en) | 2016-03-02 | 2022-03-15 | The Brigham And Women's Hospital, Inc. | Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation |
| EP3590951A4 (de) * | 2017-03-02 | 2021-01-06 | Glytech, Inc. | Herstellungsverfahren für aminosäurepolymer |
| KR20210072021A (ko) | 2018-10-01 | 2021-06-16 | 유니베르시떼 드 제네브 | 생물학 분석에 적합한 복수의 폴리펩티드 변이체의 생산 방법 |
| KR102769851B1 (ko) * | 2018-11-30 | 2025-02-20 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 펩티드 티오에스테르 및 펩티드의 신규 제조 방법 |
| AU2020361681A1 (en) | 2019-10-10 | 2022-05-05 | 1859, Inc. | Methods and systems for microfluidic screening |
| US20210230218A1 (en) * | 2019-10-23 | 2021-07-29 | Mabplex International, Ltd. | Oligopeptide linker intermediate and preparation method thereof |
| WO2022266467A2 (en) | 2021-06-17 | 2022-12-22 | Dana-Farber Cancer Institute, Inc. | Recombinant histone polypeptide and uses thereof |
| WO2024146707A1 (en) | 2023-01-06 | 2024-07-11 | Université De Genève | Variant ligand conjugates for payload delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5064940A (en) * | 1988-05-11 | 1991-11-12 | Protein Technologies, Inc. | Premixed dry reagent containing a protected amino acid and an activating agent for use in solid phase protein synthesis |
| US5101059A (en) * | 1989-12-05 | 1992-03-31 | Research Corporation Technologies, Inc. | Amino acid protecting groups |
| DK0832096T3 (da) * | 1995-05-04 | 2001-10-01 | Scripps Research Inst | Syntese af proteiner ved nativ kemisk ligering |
| JP4358307B2 (ja) * | 1996-12-24 | 2009-11-04 | ザ スクリップス リサーチ インスティテュート | 一般的化学結合 |
| DE69837170T2 (de) * | 1997-06-13 | 2007-11-22 | Amylin Pharmaceuticals, Inc., San Diego | Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen |
| US6329468B1 (en) * | 2000-01-21 | 2001-12-11 | Bostik Findley, Inc. | Hot melt adhesive based on semicrystalline flexible polyolefins |
-
1998
- 1998-06-12 DE DE69837170T patent/DE69837170T2/de not_active Expired - Fee Related
- 1998-06-12 AT AT04029270T patent/ATE354584T1/de not_active IP Right Cessation
- 1998-06-12 US US09/097,094 patent/US6326468B1/en not_active Expired - Fee Related
- 1998-06-12 EP EP98929035A patent/EP1001968B1/de not_active Expired - Lifetime
- 1998-06-12 AT AT98929035T patent/ATE285415T1/de not_active IP Right Cessation
- 1998-06-12 ES ES98929035T patent/ES2235336T3/es not_active Expired - Lifetime
- 1998-06-12 CA CA002292724A patent/CA2292724A1/en not_active Abandoned
- 1998-06-12 JP JP50326799A patent/JP2002505672A/ja not_active Ceased
- 1998-06-12 DE DE69828287T patent/DE69828287T2/de not_active Expired - Fee Related
- 1998-06-12 ES ES04029270T patent/ES2282788T3/es not_active Expired - Lifetime
- 1998-06-12 WO PCT/US1998/012278 patent/WO1998056807A1/en not_active Ceased
- 1998-06-12 AU AU80695/98A patent/AU745094B2/en not_active Ceased
-
2001
- 2001-11-15 US US09/987,675 patent/US7030217B2/en not_active Expired - Fee Related
- 2001-11-15 US US09/987,655 patent/US7094871B2/en not_active Expired - Fee Related
-
2005
- 2005-05-03 US US11/119,831 patent/US20050209440A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69837170T2 (de) | 2007-11-22 |
| DE69837170D1 (de) | 2007-04-05 |
| ATE285415T1 (de) | 2005-01-15 |
| AU8069598A (en) | 1998-12-30 |
| ES2235336T3 (es) | 2005-07-01 |
| WO1998056807A1 (en) | 1998-12-17 |
| US20020132975A1 (en) | 2002-09-19 |
| US7094871B2 (en) | 2006-08-22 |
| AU745094B2 (en) | 2002-03-14 |
| US20050209440A1 (en) | 2005-09-22 |
| DE69828287D1 (de) | 2005-01-27 |
| CA2292724A1 (en) | 1998-12-17 |
| EP1001968A1 (de) | 2000-05-24 |
| US20020169282A1 (en) | 2002-11-14 |
| JP2002505672A (ja) | 2002-02-19 |
| ES2282788T3 (es) | 2007-10-16 |
| EP1001968B1 (de) | 2004-12-22 |
| US6326468B1 (en) | 2001-12-04 |
| DE69828287T2 (de) | 2005-12-15 |
| US7030217B2 (en) | 2006-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69828287D1 (de) | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen | |
| Dongré et al. | Influence of peptide composition, gas-phase basicity, and chemical modification on fragmentation efficiency: evidence for the mobile proton model | |
| Han et al. | Ion trap collisional activation of c and z• ions formed via gas-phase ion/ion electron transfer dissociation | |
| NO993341L (no) | Analoger av paratyroidhormon | |
| EA200000190A1 (ru) | Водные аэрозольные препараты, содержащие биологически активные макромолекулы, и способ получения соответствующих аэрозолей | |
| GB9822692D0 (en) | Chemical ionization source for mass spectrometry | |
| ATE214419T1 (de) | Heisshärtende wäschefeste rohbau-versiegelung | |
| WO2003057845A3 (en) | Automated systems and methods for analysis of protein post-translational modification | |
| DE69732250D1 (de) | Zyklische peptide mit breitspektrum antimikrobieller aktivität | |
| DK0881906T4 (da) | Farmaceutisk sammensætning til immunmodulation, som er baseret på peptider og adjuvanser | |
| CA2163426A1 (en) | Method and apparatus for desorption and ionization of analytes | |
| ATE197307T1 (de) | Neuroaktive peptide | |
| GB2308227A8 (en) | Electrospray and atmospheric pressure chemical ionization mass spectrometer and ion source | |
| Leymarie et al. | Tandem mass spectrometry for structural characterization of proline-rich proteins: application to salivary PRP-3 | |
| AU4052389A (en) | Derivatized glass supports for peptide and protein sequencing | |
| NO995891L (no) | LH-RH peptidanaloger, anvendelser og farmasoeytiske blandinger inneholdende disse | |
| EP1983059A3 (de) | Reaktionsgemische zur Herstellung von Dipeptiden | |
| Kidwell et al. | Sequencing of peptides by secondary ion mass spectrometry | |
| AU8812498A (en) | Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest | |
| GB0113657D0 (en) | Improved native chemical ligation with three or more components | |
| GB9816514D0 (en) | Novel method | |
| AUPR378001A0 (en) | Protein chip | |
| WO1999020760A3 (en) | Herg family potassium ion channel genes and protein | |
| WO2002037121A3 (en) | Detection of modified amino acids by mass spectrometry | |
| AU2002322506A1 (en) | Non-affinity based isotope tagged peptides and methods for using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |